Methylene Blue MMX® (Lucipera)
Detection of colorectal polyps
ApprovedCommercial (CE Mark)
Key Facts
Indication
Detection of colorectal polyps
Phase
Approved
Status
Commercial (CE Mark)
Company
About Cosmo Pharmaceuticals
Cosmo Pharmaceuticals is a publicly traded, revenue-generating biopharmaceutical company with a strategic focus on gastroenterology. Its core expertise lies in the MMX® multi-matrix system, a proprietary technology enabling targeted topical delivery of drugs to the colon. The company's strategy combines the commercialization of its approved products, like Uceris® and Methylene Blue MMX®, with the advancement of its clinical pipeline, including novel candidates for ulcerative colitis and Crohn's disease, while also engaging in strategic licensing and partnership agreements.
View full company profile